ATXS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 151987 min ago

@ $14.28

Išleistas: 14 vas. 2024 @ 19:06

Grąža: -37.18%

Ankstesnis signalas: vas. 13 - 21:46

Ankstesnis signalas: Pardavimas

Grąža: -0.35 %

Live Chart Being Loaded With Signals

Commentary (29 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	831 515
Vidutinė apimtis	996 857
Rinkos kapitalizacija	492.57M
EPS	$0 ( 2024-05-09 )
Kita pelno data	( $-0.360 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.74
ATR14	$0.0120 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Agarwal Sunil	Buy	28 200	Stock Option (Right to Buy)
2024-04-05	Agarwal Sunil	Buy	0
2024-04-01	Morabito Christopher	Sell	10 000	Stock Option (Right to Buy)
2024-04-01	Morabito Christopher	Buy	10 000	Common Stock
2024-04-01	Morabito Christopher	Sell	10 000	Common Stock

INSIDER POWER
96.99
Last 97 transactions
Buy: 15 860 733 \| Sell: 474 752

Tūris Koreliacija

Ilgas: -0.01 (neutral)

Trumpas: -0.11 (neutral)

Signal:(49.261) Neutral

Astria Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM	1
OCEA	0.976
PMNT	0.956
HPKEW	0.949
KRSOX	0.948
ABLV	0.943
RVYL	0.943
ATLCL	0.937
IPSC	0.936
MLGO	0.934

10 Labiausiai neigiamai susiję koreliacijos
DTI	-0.965
CNRLX	-0.945
CCSB	-0.94
OPTZ	-0.939
ISRL	-0.923
EVERX	-0.922
FORL	-0.922
BAYA	-0.915
IPXX	-0.914
QTTB	-0.91

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Astria Therapeutics, Inc. Koreliacija - Valiuta/Žaliavos

-0.77
( moderate negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.41
( neutral )

0.07
( neutral )

0.35
( neutral )

Astria Therapeutics, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-2.42

FY	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-2.42

FY	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-3.43

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-49.16

Financial Reports:

No articles found.

Astria Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.